Skip to content
IsraelNational.News
Menu
Israel
Entertain
Tech
Sports
World
Business
Science
Health
IsraelNational.News
Menu
Israel
Entertain
Tech
Sports
World
Business
Science
Health
Glycoprotein
ChAdOx1 nCoV-19 vaccine does not protect against South African SARS-CoV-2 variant
N501Y mutation in SARS-CoV-2 responsible for increased viral transmission
Spinal cord-free energy study of SARS-CoV-2 anxiety modifications
SARS-CoV-2 D614G mutation associated with lower antibody binding
Researchers identify new drug target for Ebola viruses, Marburg
Novel neutral antibodies are found targeting the SARS-CoV-2 N-terminal domain
Study shows that P681H mutation is becoming more common globally among SARS-CoV-2 strains
.jpg?fit=300%2C300&ssl=1 "ChAdOx1 nCoV-19 vaccine does not protect against South African SARS-CoV-2 variant")
.jpg?fit=300%2C300&ssl=1 "N501Y mutation in SARS-CoV-2 responsible for increased viral transmission")
.jpg?fit=300%2C300&ssl=1 "SARS-CoV-2 D614G mutation associated with lower antibody binding")
